These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11714907)

  • 1. CI-988 inhibits growth of small cell lung cancer cells.
    Moody TW; Jensen RT
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1154-60. PubMed ID: 11714907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Gilbert JA; Frederick LM; Ames MM
    Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proliferation by L-myc antisense DNA for the translational initiation site in human small cell lung cancer.
    Dosaka-Akita H; Akie K; Hiroumi H; Kinoshita I; Kawakami Y; Murakami A
    Cancer Res; 1995 Apr; 55(7):1559-64. PubMed ID: 7882365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
    Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
    Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3.
    Tanno S; Ohsaki Y; Nakanishi K; Toyoshima E; Kikuchi K
    Lung Cancer; 2004 Oct; 46(1):11-9. PubMed ID: 15364128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAI inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Moody E; Sieczkiewicz GJ; Kohn EC
    Lung Cancer; 2003 Mar; 39(3):279-88. PubMed ID: 12609566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.
    Moody TW; Nuche-Berenguer B; Moreno P; Jensen RT
    J Mol Neurosci; 2015 Jul; 56(3):663-72. PubMed ID: 25761747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
    Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P; Allegrini PR; Brandt R; Brueggen J; Cozens R; Fabbro D; Grosios K; Lane HA; McSheehy P; Mestan J; Meyer T; Tang C; Wartmann M; Wood J; Caravatti G
    Cancer Res; 2004 Jul; 64(14):4931-41. PubMed ID: 15256466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells.
    Moody TW; Chiles J; Casibang M; Moody E; Chan D; Davis TP
    Peptides; 2001 Jan; 22(1):109-15. PubMed ID: 11179604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpeptide gastrin releasing peptide receptor antagonists inhibit the proliferation of lung cancer cells.
    Moody TW; Leyton J; Garcia-Marin L; Jensen RT
    Eur J Pharmacol; 2003 Aug; 474(1):21-9. PubMed ID: 12909192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
    Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
    Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed "dipeptoid" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.
    Drysdale MJ; Pritchard MC; Horwell DC
    J Med Chem; 1992 Jul; 35(14):2573-81. PubMed ID: 1635058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin stimulates Ca2+ mobilization and clonal growth in small cell lung cancer cells.
    Sethi T; Rozengurt E
    Cancer Res; 1992 Nov; 52(21):6031-5. PubMed ID: 1327522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of CCK-B antagonists.
    Horwell DC
    Neuropeptides; 1991 Jul; 19 Suppl():57-64. PubMed ID: 1881533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
    Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate efficiently achieves therapeutic intratumor concentrations in vivo but has limited activity in a xenograft model of small cell lung cancer.
    Wolff NC; Randle DE; Egorin MJ; Minna JD; Ilaria RL
    Clin Cancer Res; 2004 May; 10(10):3528-34. PubMed ID: 15161712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists.
    Singh L; Field MJ; Hill DR; Horwell DC; McKnight AT; Roberts E; Tang KW; Woodruff GN
    Eur J Pharmacol; 1995 Nov; 286(2):185-91. PubMed ID: 8605955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of BW2258U89, a GRP receptor antagonist.
    Marquez C; Treston A; Moody E; Jakowlew S; Moody TW
    Neuropeptides; 2000 Apr; 34(2):108-15. PubMed ID: 10985927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin dipeptoid antagonists: design, synthesis, and anxiolytic profile of some novel CCK-A and CCK-B selective and "mixed" CCK-A/CCK-B antagonists.
    Boden PR; Higginbottom M; Hill DR; Horwell DC; Hughes J; Rees DC; Roberts E; Singh L; Suman-Chauhan N; Woodruff GN
    J Med Chem; 1993 Mar; 36(5):552-65. PubMed ID: 7684452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.